CN114014883A - Organic boron compound and application thereof in organic electroluminescent device - Google Patents

Organic boron compound and application thereof in organic electroluminescent device Download PDF

Info

Publication number
CN114014883A
CN114014883A CN202111444668.1A CN202111444668A CN114014883A CN 114014883 A CN114014883 A CN 114014883A CN 202111444668 A CN202111444668 A CN 202111444668A CN 114014883 A CN114014883 A CN 114014883A
Authority
CN
China
Prior art keywords
substituted
unsubstituted
compound
formula
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202111444668.1A
Other languages
Chinese (zh)
Inventor
穆广园
庄少卿
彭一龙
张诒
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hubei Sunshine Optoelectronics Material Co ltd
Original Assignee
Hubei Sunshine Optoelectronics Material Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hubei Sunshine Optoelectronics Material Co ltd filed Critical Hubei Sunshine Optoelectronics Material Co ltd
Priority to CN202111444668.1A priority Critical patent/CN114014883A/en
Publication of CN114014883A publication Critical patent/CN114014883A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/027Organoboranes and organoborohydrides
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/631Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
    • H10K85/636Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine comprising heteroaromatic hydrocarbons as substituents on the nitrogen atom
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6574Polycyclic condensed heteroaromatic hydrocarbons comprising only oxygen in the heteroaromatic polycondensed ring system, e.g. cumarine dyes
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6576Polycyclic condensed heteroaromatic hydrocarbons comprising only sulfur in the heteroaromatic polycondensed ring system, e.g. benzothiophene
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1011Condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1074Heterocyclic compounds characterised by ligands containing more than three nitrogen atoms as heteroatoms
    • C09K2211/1085Heterocyclic compounds characterised by ligands containing more than three nitrogen atoms as heteroatoms with other heteroatoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1088Heterocyclic compounds characterised by ligands containing oxygen as the only heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1092Heterocyclic compounds characterised by ligands containing sulfur as the only heteroatom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Organic Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Electroluminescent Light Sources (AREA)

Abstract

The invention relates to an organic boron compound and application thereof in an organic electroluminescent device, belonging to the technical field of photoelectric materials. The compound is a main body formed by bonding imidazopyridine with group nitrogen such as arylamine, carbazole, acridine and the like, the center of the main body is modified by boron, the compound has a rigid large conjugated structure, the supply/receiving electricity of the compound is adjusted by the bipolar imidazopyridine group, and the HOMO of the compound is reduced, so that a device prepared by using the compound as a luminescent layer material shows stable and efficient deep blue light emission, and the device is remarkably improved in the aspects of driving voltage, current efficiency, light color and service life.

Description

Organic boron compound and application thereof in organic electroluminescent device
Technical Field
The invention relates to the field of photoelectric materials, in particular to an organic boron compound and application thereof in an organic electroluminescent device.
Background
An organic electroluminescent device (OLED) includes a cathode, an anode, and an organic layer between the two electrodes, and the organic layer includes a hole transport layer, an electron transport layer, a light emitting layer, and the like. Under the drive of an external electric field, holes and electrons are firstly injected from the anode and the cathode respectively, then move oppositely in the hole transport layer and the electron transport layer, and are then compounded into exciton radiation transition in the luminescent layer to emit various colors of light.
In order to apply the OLED to full color display, it is a primary problem to implement a rgb three-color device having high efficiency. Currently, for green and red OLEDs, a light emitting material based on a phosphorescence and Thermally Activated Delayed Fluorescence (TADF) mechanism has achieved 100% internal quantum efficiency, and has achieved mass industrialization, being widely used in commercial full color display devices. However, the deep blue OLED material with high quality display has not achieved a significant breakthrough all the time, the blue material has a wide band gap, the carrier transfer and energy transfer processes in the electroluminescence process are difficult and unstable, and the mutual quenching and deactivation phenomenon among excitons under high current density is very serious, so that most deep blue devices have very serious device efficiency roll-off and low brightness, and the service life is very short.
In recent years, a novel organic unit material of pi-conjugate containing organic boron and nitrogen in a co-insertion mode has good photophysical and electrochemical properties, so that the organic unit material becomes a research hotspot of a blue-light OLED material system, imidazole has acidity and alkalinity simultaneously, is a bipolar compound, is applied to the blue-light OLED material, and has important significance for adjusting the balance of current carriers.
Disclosure of Invention
The invention aims to provide an organic boron compound and application thereof in an organic electroluminescent device, and improves the carrier transmission balance of the current deep blue light luminescent material, so that the deep blue light OLED device has excellent comprehensive properties in the aspects of luminous efficiency, stability, light color, service life and the like.
The invention provides an organic boron compound, the structural general formula of which is shown in formula (1):
Figure BDA0003384579950000021
wherein the content of the first and second substances,
Figure BDA0003384579950000022
are the same or different and are each independently represented by a void or a single bond or-X0-,X0Selected from O, S, N (R)2) And C (R)3)(R4) Any one of the above;
Ar、Ar1and Ar2Are the same or different from each other, and are each independently selected from a benzene ring, a condensed aromatic ring having not more than 18 carbon atoms, a condensed aromatic heterocyclic ring having not more than 18 carbon atoms, R1Substituted benzene ring, R1A substituted fused aromatic ring having not more than 18 carbon atoms and R1Any one of condensed aromatic heterocyclic rings having not more than 18 carbon atoms in substitution;
R0selected from hydrogen, fluoro, nitro, cyano, C1-12Alkyl of (C)6-30Aryl of (C)3-30Heteroaryl and C6-30Any one of the arylamine groups of (a);
R1selected from hydrogen, fluoro, nitro, cyano, C1-12Alkyl of (C)1-12Alkoxy group of (C)3-12Cycloalkyl of, C2-20Heterocycloalkyl of (A), C6-30Aryl of (C)3-30Heteroaryl and C6-30Any one of the arylamine groups of (a);
R2-R4are the same or different from each other and are each independently selected from C1-12Alkyl and C6-30Any one of the aryl groups of (1).
Further, Ar1And Ar2The same or different from each other, each independently selected from any one of the following: unsubstituted or substituted by R1Substituted benzenes, unsubstituted or substituted by R1Substituted naphthalenes, unsubstituted or substituted by R1Substituted dibenzofurans, unsubstituted or substituted by R1Substituted dibenzothiophenes, unsubstituted or substituted by R1Substituted 9, 9-dimethylfluorenes, unsubstituted or substituted by R1Substituted carbazoles wherein the symbols and indices used have the meanings given in claim 1. Namely, R1Is defined as in the above chemical formula 11The same is true.
Further, when Ar, Ar1And Ar2Each independently of the other being unsubstituted or substituted by R1When substituted benzene, the organoboron compound is a compound represented by the formula 1-1:
Figure BDA0003384579950000031
when Ar, Ar1Each independently of the other being unsubstituted or substituted by R1Substituted benzenes, and Ar2Is unsubstituted or substituted by R1Substituted naphthalenes, unsubstituted or substituted by R1Substituted dibenzofurans, unsubstituted or substituted by R1Substituted dibenzothiophenes, unsubstituted or substituted by R1Substituted 9, 9-dimethylfluorenes, unsubstituted or substituted by R1When any one of the substituted carbazoles is used, the organoboron compound is a compound represented by the formula 1-2:
Figure BDA0003384579950000041
when Ar is unsubstituted or substituted by R1Substituted naphthalenes, unsubstituted or substituted by R1Substituted dibenzofurans, unsubstituted or substituted by R1Substituted dibenzothiophenes, unsubstituted or substituted by R1Substituted 9, 9-dimethylfluorenes, unsubstituted or substituted by R1Any one of substituted carbazoles, and Ar2Is unsubstituted or substituted by R1When substituted benzene, the organoboron compound is a compound represented by formula 1 to 3 or formula 1 to 4:
Figure BDA0003384579950000042
when Ar, Ar2Each independently of the others being unsubstituted or substituted by R1Substituted naphthalenes, unsubstituted or substituted by R1Substituted dibenzofurans, unsubstituted or substituted by R1Substituted dibenzothiophenes, unsubstituted or substituted by R1Substituted 9, 9-dimethylfluorenes, unsubstituted or substituted by R1Any of the substituted carbazolesIn this case, the organoboron compound is a compound represented by the formula 1 to 5 or the formula 1 to 6:
Figure BDA0003384579950000051
wherein Ar is1、Ar2Is defined by the formula (I) and Ar in claim 21、Ar2The definitions of (A) and (B) are the same,
Figure BDA0003384579950000052
is as defined in formula 1 above
Figure BDA0003384579950000053
In the same way, the first and second,
R0is as defined in the above formula 10In the same way, the first and second,
R1is as defined in the above formula 11In the same way, the first and second,
R5、R6、R7is as defined in the above formula 11In the same way, the first and second,
z is selected from O, S, C (CH)3)2And N (Ph).
Further, R2Is any one of phenyl which is unsubstituted or substituted by fluoro, nitro, cyano, methyl and tert-butyl.
Further, R3And R4The same as each other, are each methyl.
Further, R1Selected from: hydrogen, fluoro, nitro, cyano, methyl, tert-butyl, phenyl which is unsubstituted or substituted by fluoro, nitro, cyano, methyl, tert-butyl, phenyl.
Further, R0Independently any one of hydrogen, fluoro, nitro, cyano, methyl, tert-butyl, phenyl unsubstituted or substituted by fluoro, nitro, cyano, methyl, tert-butyl, biphenyl, a group of formula A1, a group of formula A2 and a group of formula A3:
Figure BDA0003384579950000054
wherein, X1Selected from O, S, N (R)8)、C(R9)(R10),R8-R10The phenyl groups are the same or different from each other and are independently selected from any one of methyl, phenyl which is unsubstituted or substituted by fluoro, nitro, cyano, methyl and tert-butyl.
Further, the organoboron compound shown in the formula 1 is selected from any one of the following structural formulas:
Figure BDA0003384579950000061
Figure BDA0003384579950000071
Figure BDA0003384579950000081
Figure BDA0003384579950000091
in a second aspect, the present invention provides an organic electroluminescent device comprising a cathode, an anode and an organic layer disposed between the cathode and the anode, the organic layer comprising an organoboron compound of any of the above.
Further, the organic layer between the two electrodes includes a light-emitting layer containing any of the organoboron compounds described above.
The organic boron compound provided by the invention is used for forming a receptor type main body framework by linking imidazole pyridine with strong electron deficiency property and radical nitrogen with electron donating property such as arylamine, carbazole, acridine and the like, and the mobility of current carriers on the whole compound is more balanced, so that higher fluorescence quantum yield can be obtained, and the center of the main body is modified by boron to form a rigid large conjugated structure, so that the HOMO of the compound is reduced, a wider band gap is obtained, stable deep blue light emission can be realized, and better thermodynamic stability can be obtained, and the organic boron compound is further applied to an organic electroluminescent device and has remarkable advantages in the aspects of starting voltage, luminous efficiency, service life and the like of the device.
Detailed Description
It should be understood that the detailed description and specific examples, while indicating the present invention, are given by way of illustration and explanation only, not limitation.
Synthesis example 1: synthesis of Compound (7)
S1: after 3-bromoimidazo [1,2-a ] pyridine (35mmol,6.90g), 2, 3-dichloro-5-fluoro-mesitylene (30mmol,8.95g), sodium tert-butoxide (60mmol,5.76g), tris (dibenzylideneacetone) dipalladium (0.15mmol,0.14g), tris (tert-butylphosphine) tetrafluoroborate (0.15mmol,0.04g) and 100mL of toluene were charged into a reactor, they were sufficiently stirred and mixed, and then heated under nitrogen protection for reflux reaction, after completion of liquid phase monitoring reaction, they were cooled to room temperature, diphenylamine (30mmol,5.08g) was charged, and they were sufficiently stirred and mixed, and under nitrogen protection, they were further heated under reflux reaction, after completion of liquid phase monitoring reaction, they were cooled to room temperature, the reaction solution was extracted with a mixture of water and dichloromethane, dried and concentrated, and purified and separated in a silica gel column with a mixed solvent of 1:10 dichloromethane and petroleum ether, 10.18g of a compound represented by the following chemical formula (7a) was obtained in a yield of 62%;
Figure BDA0003384579950000111
s2: after the compound represented by the above formula (7a) (15mmol,8.21g), 10-hydro-phenoxazine (20mmol,3.66g), cesium carbonate (22.5mmol,7.33g) and 100mL of N, N-dimethylformamide were charged into a reactor, and sufficiently stirred and mixed, a reflux reaction was performed under heating under nitrogen protection, the liquid phase monitoring reaction was completed, cooling to room temperature was performed, 50mL to 100mL of water was added, filtration was performed, the filtrate was extracted with dichloromethane for 2 times, concentrated, and slurried with ethanol for 2 times together with the cake, whereby 8.52g of the compound represented by the following formula (7b) was obtained with a yield of 80%;
Figure BDA0003384579950000112
s3: dissolving the compound (10mmol,7.10g) represented by the formula (7b) in 50mL of tert-butyl benzene solution in a reactor, cooling the reaction solution to-40 ℃, slowly adding 32.5mL of 2.5M N-hexane tert-butyl lithium solution dropwise under the protection of nitrogen, stirring for 0.5-2h while maintaining the temperature, adding boron tribromide (15mmol,3.76g), heating the reaction solution to room temperature, stirring for 0.5-2h, cooling the reaction solution to 0 ℃, adding N, N-diisopropylethylamine (10mmol,1.29g), heating to 120 ℃ for reflux reaction, monitoring the completion of the reaction in a liquid phase, cooling to room temperature, quenching the reaction solution with acetic acid, extracting the reaction solution with a mixture of water and dichloromethane, drying an organic phase magnesium sulfate, concentrating, purifying and separating in a silica gel column with a mixed solvent of 1:10 dichloromethane and petroleum ether to obtain 2.39g of the compound represented by the following formula (7), the yield is 35 percent;
Figure BDA0003384579950000121
the compound obtained was analyzed and found to have the following results: mass spectrometer MALDI-TOF-MS (m/z) 683.6275; nuclear magnetism δ (ppm) is 9.02(1H), 8.79(1H), 8.45(1H), 7.78(2H), 7.70(1H), 7.62(1H), 7.47(1H), 7.35(2H), 7.22(1H), 6.89-6.95(4H)6.77(2H), 6.70(1H), 6.59(2H), 6.26(1H), 6.02(2H), 5.22(2H), 2.20 (9H).
Synthesis example 2: synthesis of Compound (13)
S1: the same procedures as in example 1 were repeated except for replacing 2, 3-chloro-5-fluoro-mesitylene in S1 with 2, 3-dichloro-N-diphenylamine (30mmol,7.14g) and replacing diphenylamine with 3, 6-diphenyl-9-hydro-carbazole (30mmol,9.58g) in example 1 to give 11.09g of a compound represented by the following formula (13a) in a yield of 58%;
Figure BDA0003384579950000122
s2: the same procedures used in example 1 were repeated except for replacing the compound represented by (7b) in S3 in example 1 with 6.37g of the compound represented by (13a) described in this example, whereby 1.89g of the compound represented by the following chemical formula (13) was obtained in a yield of 31%;
Figure BDA0003384579950000131
the compound obtained was analyzed and found to have the following results: mass spectrometer MALDI-TOF-MS (m/z) 610.5309; nuclear magnetism δ (ppm) is 9.05(1H), 8.90(1H), 8.76(1H), 8.45(1H), 8.22(1H), 8.06(1H), 7.95(1H), 7.81-7.87(4H), 7.72(2H), 7.62(3H), 7.48(2H), 7.32(2H), 7.20(2H), 7.05(1H), 6.73(1H), 6.25(1H), 6.14 (2H).
Synthetic example 3: synthesis of Compound (26)
S1: the same procedures used in example 1 were repeated except for replacing 2, 3-chloro-5-fluoro-mesitylene amine in S1 with N- (2, 3-dichlorophenyl) - [1,1' -biphenyl ] -4-amine (30mmol,9.43g) and diphenylamine with 5- (p-tolyl) -5, 10-dihydrophenazine (30mmol,8.17g) in example 1 to give 12.79g of the compound represented by the following formula (26a) in a yield of 64%;
Figure BDA0003384579950000132
s2: the same procedures used in example 1 were repeated except for replacing the compound represented by (7b) in S3 in example 1 with 6.66g of the compound represented by (26a) in this example to give 2.11g of the compound represented by the following formula (26) in a yield of 33%;
Figure BDA0003384579950000141
the compound obtained was analyzed and found to have the following results: mass spectrometer MALDI-TOF-MS (m/z) 639.5615; nuclear magnetism δ (ppm) is 9.03(1H), 8.42(1H), 8.11(1H), 7.78(2H), 7.71(1H), 7.63(1H), 7.55(2H), 7.48(2H), 7.40(1H), 7.32(2H), 7.27(1H), 7.21(2H), 7.16(1H), 6.97-7.03(5H), 6.89(1H), 6.26(1H), 6.14(2H), 2.26 (3H).
Synthetic example 4: synthesis of Compound (28)
S1: the same procedures as in example 1 were repeated except for replacing diphenylamine in S1 with 10-hydrogen-phenothiazine (30mmol,5.98g) in example 1 to give 10.39g of a compound represented by the following formula (28a) in a yield of 60%;
Figure BDA0003384579950000142
s2: the same procedures as in example 1 were repeated except for replacing (7a) in S2 with 8.66g of the compound represented by the above-mentioned (28a) in example 1 and replacing 10 h-phenoxazine with 9 h-carbazole (20mmol,3.34g), thereby obtaining 9.02g of the compound represented by the following formula (28b) with a yield of 83%;
Figure BDA0003384579950000151
s3: the same procedures used in example 1 were repeated except for replacing the compound represented by (7b) in S3 in example 1 with 7.24g of the compound represented by (28b) described in this example, whereby 2.52g of the compound represented by the following chemical formula (28) was obtained in a yield of 36%;
Figure BDA0003384579950000152
the compound obtained was analyzed and found to have the following results: mass spectrometer MALDI-TOF-MS (m/z) 697.6698; nuclear magnetism δ (ppm) is 9.10(1H), 8.47(1H), 8.18(2H), 7.95(1H), 7.83(1H), 7.75(2H), 7.64(1H), 7.50(2H), 7.21(3H), 7.12(1H), 7.00(1H), 6.87-6.94(4H), 6.80(2H), 6.31(1H), 2.20 (9H).
Synthesis example 5: synthesis of Compound (33)
S1: the same procedures as in example 1 were repeated except for replacing 2, 3-chloro-5-fluoro-mesitylene in S1 in example 1 with 2-chloro-9-hydro-carbazole (30mmol,6.05g) and replacing diphenylamine with 4,4' -dicyanodianiline (30mmol,6.58g), to give 8.56g of a compound represented by the following formula (33a) in a yield of 57%;
Figure BDA0003384579950000161
s2: the same procedures used in example 1 were repeated except for replacing the compound represented by (7b) in S3 in example 1 with 5.01g of the compound represented by (33a) described in this example, whereby 1.73g of the compound represented by the following chemical formula (33) was obtained in a yield of 34%;
Figure BDA0003384579950000162
the compound obtained was analyzed and found to have the following results: the mass spectrometer MALDI-TOF-MS (m/z) was 508.3561.
Synthetic example 6: synthesis of Compound (39)
S1: the same procedures as in example 1 were repeated except for replacing 2, 3-chloro-5-fluoro-mesitylene in S1 in example 1 with 2-chloro-10-hydro-phenothiazine (30mmol,7.01g) and replacing diphenylamine with bis (4- (tert-butyl) phenyl) amine (30mmol,8.44g), thereby obtaining 10.53g of a compound represented by the following formula (39a) in a yield of 59%;
Figure BDA0003384579950000163
s2: the same procedures used in example 1 were repeated except for replacing the compound represented by (7b) in S3 in example 1 with 5.95g of the compound represented by (39a) described in this example, whereby 1.87g of the compound represented by the following formula (39) was obtained in a yield of 31%;
Figure BDA0003384579950000171
the compound obtained was analyzed and found to have the following results: the mass spectrometer MALDI-TOF-MS (m/z) was 602.6023.
Synthetic example 7: synthesis of Compound (46)
S1: the same procedures as in example 1 were repeated except for replacing 2, 3-chloro-5-fluoro-mesitylene in S1 in example 1 with 2-chloro-9-hydro-carbazole (30mmol,6.05g), 3-bromoimidazo [1,2-a ] pyridine with 3-bromo-7-phenylimidazo [1,2-a ] pyridine (35mmol,9.56g) and diphenylamine with 9-hydro-carbazole (30mmol,5.02g), to give 9.60g of the compound represented by the following formula (46a) in a yield of 61%;
Figure BDA0003384579950000172
s2: the same procedures used in example 1 were repeated except for replacing the compound represented by (7b) in S3 in example 1 with 5.25g of the compound represented by (46a) described in this example, whereby 1.86g of the compound represented by the following formula (46) was obtained in a yield of 35%;
Figure BDA0003384579950000181
the compound obtained was analyzed and found to have the following results: the mass spectrometer MALDI-TOF-MS (m/z) was 532.4167.
Synthesis example 8: synthesis of Compound (49)
S1: the same procedures as in example 1 were repeated except for replacing 2, 3-chloro-5-fluoro-mesitylene in S1 in example 1 with 2-chloro-9-hydro-carbazole (30mmol,6.05g), diphenylamine with 9, 9-dimethyl-9, 10-dihydroacridine (30mmol,6.28g), to give 9.57g of a compound represented by the following formula (49a) in a yield of 65%;
Figure BDA0003384579950000182
s2: the same procedures used in example 1 were repeated except for replacing the compound represented by (7b) in S3 in example 1 with 4.91g of the compound represented by (49a) described in this example, whereby 1.84g of the compound represented by the following formula (49) was obtained in a yield of 37%;
Figure BDA0003384579950000183
the compound obtained was analyzed and found to have the following results: the mass spectrometer MALDI-TOF-MS (m/z) was 498.3928.
Synthetic example 9: synthesis of Compound (52)
S1: the same procedures as in example 1 were repeated except for replacing 2, 3-chloro-5-fluoro-mesitylene amine in S1 with 2-chloro-10 h-phenoxazine (30mmol,6.53g) and replacing diphenylamine with 10 h-phenoxazine (30mmol,5.50g) in example 1 to give 9.08g of a compound represented by the following formula (52a) in a yield of 63%;
Figure BDA0003384579950000191
s2: the same procedures used in example 1 were repeated except for replacing the compound represented by (7b) in S3 in example 1 with 4.81g of the compound represented by (52a) described in this example, whereby 1.66g of the compound represented by the following formula (52) was obtained in a yield of 34%;
Figure BDA0003384579950000192
the compound obtained was analyzed and found to have the following results: the mass spectrometer MALDI-TOF-MS (m/z) was 488.3175.
Synthetic example 10: synthesis of Compound (58)
S1: the same procedures as in example 1 were repeated except for replacing 2, 3-chloro-5-fluoro-mesitylene amine in S1 with 2-chloro-5-phenyl-5, 10-dihydrophenazine (30mmol,8.78g) and replacing diphenylamine with 3, 6-difluoro-9-hydro-carbazole (30mmol,6.10g) in example 1 to obtain 10.36g of a compound represented by the following formula (58a) in a yield of 60%;
Figure BDA0003384579950000201
s2: the same procedures used in example 1 were repeated except for replacing the compound represented by (7b) in S3 in example 1 with 5.76g of the compound represented by (58a) described in this example, whereby 1.87g of the compound represented by the following formula (58) was obtained in a yield of 32%;
Figure BDA0003384579950000202
the compound obtained was analyzed and found to have the following results: the mass spectrometer MALDI-TOF-MS (m/z) was 583.4043.
Synthetic example 11: synthesis of Compound (65)
S1: the same procedures as in example 1 were repeated except for replacing 2, 3-chloro-5-fluoro-mesitylene in S1 in example 1 with (2, 3-dichloro-5-fluorophenyl) naphthalen-2-amine (30mmol,9.18g) and replacing diphenylamine with 9-hydro-carbazole (30mmol,5.02g), to obtain 9.13g of a compound represented by the following formula (65a) in a yield of 55%;
Figure BDA0003384579950000203
s2: the same procedure as in example 1 was repeated except for replacing (7a) in S2 with 8.30g of the compound represented by the above-mentioned (65a) in example 1 and replacing 10-hydro-phenoxazine with diphenylamine (20mmol,3.38g), thereby obtaining g of the compound represented by the following formula (65b) in a yield of 81%;
Figure BDA0003384579950000211
s3: the same procedures used in example 1 were repeated except for replacing the compound represented by (7b) in S3 in example 1 with 7.02g of the compound represented by (65b) described in this example to give 2.50g of the compound represented by the following formula (65) in a yield of 37%;
Figure BDA0003384579950000212
the compound obtained was analyzed and found to have the following results: mass spectrometer MALDI-TOF-MS (m/z) 675.6066; nuclear magnetic δ (ppm) is 9.04(1H), 8.67(1H), 8.47(1H), 8.18(1H), 7.98(2H), 7.87(1H), 7.70(1H), 7.60(1H), 7.47-7.54(6H), 7.41(1H), 7.38(1H), 7.33(1H), 7.20(1H), 7.11(5H), 7.01(1H), 6.94(2H), 6.25(1H), 5.22 (2H).
Synthetic example 12: synthesis of Compound (70)
S1: the procedure of example 1 was repeated except for replacing 2, 3-chloro-5-fluoro-mesitylene in S1 in example 1 with N- (2, 3-dichloro-5-nitrophenyl) -9, 9-dimethyl-9-hydro-fluoren-2-amine (30mmol,11.98g) and replacing diphenylamine with 10-hydro-phenothiazine (30mmol,5.98g), to give 11.80g, in 58% yield, of the compound represented by the following formula (70 a);
Figure BDA0003384579950000221
s2: the same procedures used in example 1 were repeated except for replacing the compound represented by (7b) in S3 in example 1 with 6.78g of the compound represented by (70a) described in this example, whereby 2.28g of the compound represented by the following formula (70) was obtained in a yield of 35%;
Figure BDA0003384579950000222
the compound obtained was analyzed and found to have the following results: mass spectrometer MALDI-TOF-MS (m/z) 651.5478; nuclear magnetism δ (ppm) is 9.02(1H), 8.43(1H), 8.19(1H), 8.04(2H), 7.98(1H), 7.87(2H), 7.75(1H), 7.63(1H), 7.51(1H), 7.44(1H), 7.38(1H), 7.12-7.21(3H), 7.02(2H), 6.91(1H), 6.25(1H), 1.79 (6H).
Synthetic example 13: synthesis of Compound (73)
S1: the procedure of example 1 was repeated except for replacing 2, 3-chloro-5-fluoro-mesitylene in S1 in example 1 with N- (2, 3-dichlorophenyl) -2,4, 6-trimethylamine (30mmol,8.41g) and diphenylamine with N- (4- (tert-butyl) phenyl) dibenzofuran-2-amine (30mmol,9.46g), to give 10.74g of a compound represented by the following formula (73a) in a yield of 53%;
Figure BDA0003384579950000231
s2: the same procedures used in example 1 were repeated except for replacing the compound represented by (7b) in S3 in example 1 with 6.75g of the compound represented by (73a) described in this example, whereby 2.47g of the compound represented by the following formula (73) was obtained in a yield of 38%;
Figure BDA0003384579950000232
the compound obtained was analyzed and found to have the following results: mass spectrometer MALDI-TOF-MS (m/z) 648.6126; nuclear magnetism δ (ppm) is 9.06(1H), 8.45(1H), 8.33(1H), 8.05(1H), 7.74(1H), 7.61(1H), 7.63(1H), 7.43-7.51(3H), 7.36(1H), 7.25(1H), 7.13(2H), 6.95(2H), 6.23(1H), 6.14(2H), 2.20(9H), 1.35 (9H).
Synthesis example 14: synthesis of Compound (80)
S1: the same procedures as in example 1 were repeated except for replacing 2, 3-chloro-5-fluoro-mesitylene amine in S1 in example 1 with 2-chloro-10 h-phenoxazine (30mmol,6.53g) and replacing diphenylamine with N- (2, 5-dimethyl- [1,1' -biphenyl ] -4-yl) naphthalen-2-amine (30mmol,9.70g), to obtain 10.61g of a compound represented by the following formula (80a) in a yield of 57%;
Figure BDA0003384579950000241
s2: the same procedures used in example 1 were repeated except for replacing the compound represented by (7b) in S3 in example 1 with 6.21g of the compound represented by (80a) described in this example, whereby 2.08g of the compound represented by the following formula (80) was obtained in a yield of 33%;
Figure BDA0003384579950000242
the compound obtained was analyzed and found to have the following results: mass spectrometer MALDI-TOF-MS (m/z) 628.5389; nuclear magnetism δ (ppm) is 9.02(1H), 8.48(1H), 7.84(1H), 7.79(1H), 7.70(1H), 7.64(1H), 7.54(2H), 7.38-7.47(4H), 7.30(2H), 7.21(3H), 7.15(1H), 7.06(1H), 6.98(1H), 6.85(1H), 6.77(1H), 6.26(1H), 2.47(3H), 2.19 (3H).
Synthetic example 15: synthesis of Compound (81)
The same procedures as in example 1 were repeated except for replacing 2, 3-dichloro-5- (10 h-phenoxazin-10-yl) -N-diphenylamine in example 1 with N- (2, 3-dichlorophenyl) naphthalene-2-amine (30mmol,8.65g) and replacing diphenylamine with 2, 2-dinaphthylamine (30mmol,8.08g), thereby obtaining 11.28g of a compound represented by the following formula (81a) in a yield of 59%;
Figure BDA0003384579950000251
the same procedures used in example 1 were repeated except for replacing the compound represented by (7a) in example 1 with 6.37g of the compound represented by (81a) above, thereby obtaining 2.32g of the compound represented by the following formula (81) with a yield of 38%;
Figure BDA0003384579950000252
the compound obtained was analyzed and found to have the following results: mass spectrometer MALDI-TOF-MS (m/z) 610.5306; nuclear magnetism δ (ppm) is 9.03(1H), 8.44(1H), 7.75-7.87(6H), 7.61(1H), 7.54(2H), 7.49(3H), 7.43(3H), 7.38(2H), 7.31(1H), 7.26(1H), 7.06(1H), 7.01(2H), 6.25(1H), 6.14 (2H).
Device example 1
And (3) sequentially ultrasonically cleaning the glass substrate with the 50nm ITO transparent film for 10min by using acetone, isopropanol and deionized water, drying for 2h in vacuum at 105 ℃, then washing for 15min by using UV ozone, and conveying the ITO glass substrate to a vacuum evaporation machine.
Vacuum evaporating 4,4' -tris [ 2-naphthyl (phenyl) amino ] triphenylamine (2T-NATA) on the surface of the side on which the ITO film is formed to form a hole injection layer with a thickness of 80 nm;
next, on the above hole injection layer, N '-diphenyl-N, N' - (1-naphthyl) -1,1 '-biphenyl-4, 4' -diamine (NPB) was vacuum-evaporated to form a 30nm thick hole transport layer;
next, on the above hole transport layer, compound 7 prepared in the above synthesis example 1 was vacuum-evaporated to form a light emitting layer having a thickness of 30 nm;
next, on the above light-emitting layer, bis (2-methyl-8-hydroxyquinoline-N1, O8) - (1,1' -biphenyl-4-hydroxy) aluminum (BAlq) was vacuum-evaporated to form a hole-blocking layer with a thickness of 10 nm;
next, 8-hydroxyquinoline aluminum (Alq) was vacuum-evaporated on the hole-blocking layer3) To form an electron transport layer with a thickness of 20 nm;
finally, on the above electron transport layer, aluminum (Al) was vacuum-evaporated to form a cathode of 100 nm.
Device example 2 to device example 15
An organic electroluminescent device was prepared in the same manner as in device example 1, except that the compound synthesized in synthesis example 2 to synthesis example 15 described above was used instead of the compound 7 prepared in synthesis example 1 described above, respectively.
The organic electroluminescent devices prepared in the above device examples were subjected to performance tests, and the results are shown in table 1:
TABLE 1
Figure BDA0003384579950000261
Figure BDA0003384579950000271
As can be seen from the data in table 1 above, the compound provided by the present invention, in which the imidazopyridine is linked with groups such as arylamine, carbazole, acridine, etc. through a ring nitrogen bond to form the host and boron is used to modify the center of the host, has a rigid conjugated structure, and the bipolar imidazopyridine group can adjust the power supply and the power reception of the compound, and simultaneously reduce the HOMO of the compound, so that the compound material can realize stable and efficient deep blue light emission.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.

Claims (10)

1. An organic boron compound is characterized in that the structural general formula of the compound is shown as formula 1:
Figure FDA0003384579940000011
wherein the content of the first and second substances,
Figure FDA0003384579940000012
are the same or different and are each independently represented by a void or a single bond or-X0-, said X0Selected from O, S, N (R)2) And C (R)3)(R4) Any one of the above;
Ar、Ar1and Ar2Equal to or different from each other, each independently selected from: a benzene ring, a condensed aromatic ring having not more than 18 carbon atoms, a condensed aromatic heterocyclic ring having not more than 18 carbon atoms, R1Substituted benzene ring, R1A substituted fused aromatic ring having not more than 18 carbon atoms and R1Any one of condensed aromatic heterocyclic rings having not more than 18 carbon atoms in substitution;
R0selected from hydrogen, fluoro, nitro, cyano, C1-12Alkyl of (C)6-30Aryl of (C)3-30Heteroaryl and C6-30Any one of the arylamine groups of (a);
R1selected from hydrogen, fluoro, nitro, cyano, C1-12Alkyl of (C)1-12Alkoxy group of (C)3-12Cycloalkyl of, C2-20Heterocycloalkyl of (A), C6-30Aryl of (C)3-30Heteroaryl and C6-30Any one of the arylamine groups of (a);
R2-R4are the same or different from each other and are each independently selected from C1-12Alkyl and C6-30Any one of the aryl groups of (1).
2. The organoboron compound of claim 1, where Ar, Ar are Ar1And Ar2The same or different from each other, each independently selected from any one of the following: unsubstituted or substituted by R1Substituted benzenes, unsubstituted or substituted by R1Substituted naphthalenes, unsubstituted or substituted by R1Substituted dibenzofurans, unsubstituted or substituted by R1Substituted dibenzothiophenes, unsubstituted or substituted by R1Substituted 9, 9-dimethylfluorenes, unsubstituted or substituted by R1Substituted carbazoles wherein the symbols and indices used have the meanings given in claim 1.
3. The organoboron compound of claim 2, characterized in that,
when Ar, Ar1、Ar2Each independently of the other being unsubstituted or substituted by R1When substituted benzene, the organoboron compound is a compound represented by the formula 1-1:
Figure FDA0003384579940000021
when Ar, Ar1Each independently of the other being unsubstituted or substituted by R1Substituted benzenes, and Ar2Is unsubstituted or substituted by R1Substituted naphthalenes, unsubstituted or substituted by R1Substituted dibenzofurans, unsubstituted or substituted by R1Substituted dibenzothiophenes, unsubstituted or substituted by R1Substituted 9, 9-dimethylfluorenes, unsubstituted or substituted by R1When any one of the substituted carbazoles is used, the organoboron compound is a compound represented by the formula 1-2:
Figure FDA0003384579940000022
when Ar is unsubstituted or substituted by R1Substituted naphthalenes, unsubstituted or substituted by R1Substituted dibenzofurans, unsubstituted or substituted by R1Substituted dibenzothiophenes, unsubstituted or substituted by R1Substituted 9, 9-dimethylfluorenes, unsubstituted or substituted by R1Any one of substituted carbazoles, and Ar2Is unsubstituted or substituted by R1When substituted benzene, the organoboron compound is a compound represented by formula 1 to 3 or formula 1 to 4:
Figure FDA0003384579940000031
when Ar, Ar2Each independently of the others being unsubstituted or substituted by R1Substituted naphthalenes, unsubstituted or substituted by R1Substituted dibenzofurans, unsubstituted or substituted by R1Substituted dibenzothiophenes, unsubstituted or substituted by R1Substituted 9, 9-dimethylfluorenes, unsubstituted or substituted by R1When any one of the substituted carbazoles is selected, the organoboron compound is a compound represented by formula 1-5 or formula 1-6:
Figure FDA0003384579940000032
wherein Ar is1、Ar2Is defined by the formula (I) and Ar in claim 21、Ar2The definitions of (A) and (B) are the same,
Figure FDA0003384579940000033
is as defined in formula 1 above
Figure FDA0003384579940000034
Same as R0Is as defined in the above formula 10In the same way, the first and second,
R1is as defined in the above formula 11In the same way, the first and second,
R5、R6、R7is as defined in the above formula 11In the same way, the first and second,
z is selected from O, S, C (CH)3)2And N (Ph).
4. The organoboron compound of claim 1, where R is2Is any one of phenyl which is unsubstituted or substituted by fluoro, nitro, cyano, methyl and tert-butyl.
5. The organoboron compound of claim 1, where R is3And R4The same as each other, are each methyl.
6. The organoboron compound of claim 1, where R is1Is selected from any one of hydrogen, fluoro, nitro, cyano, methyl, tert-butyl, phenyl which is unsubstituted or substituted by fluoro, nitro, cyano, methyl, tert-butyl and phenyl.
7. The organoboron compound of claim 1, where R is0Independently is any of hydrogen, fluoro, nitro, cyano, methyl, tert-butyl, phenyl, biphenyl, a group of formula A1, a group of formula A2 and a group of formula A3 which are unsubstituted or substituted by fluoro, nitro, cyano, methyl, tert-butylThe method comprises the following steps:
Figure FDA0003384579940000041
wherein, X1Selected from O, S, N (R)8)、C(R9)(R10),R8-R10The phenyl groups are the same or different from each other and are independently selected from any one of methyl, phenyl which is unsubstituted or substituted by fluoro, nitro, cyano, methyl and tert-butyl.
8. The organoboron compound of claim 1, where the organoboron compound is selected from any of the following structural formulas:
Figure FDA0003384579940000051
Figure FDA0003384579940000061
Figure FDA0003384579940000071
Figure FDA0003384579940000081
9. an organic electroluminescent device comprising a cathode, an anode and an organic layer disposed between the cathode and the anode, wherein the organic layer comprises the organoboron compound of any of claims 1 to 8.
10. The organic electroluminescent device according to claim 9, wherein the organic layer comprises a light-emitting layer comprising the organoboron compound according to any one of claims 1 to 8.
CN202111444668.1A 2021-11-30 2021-11-30 Organic boron compound and application thereof in organic electroluminescent device Pending CN114014883A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111444668.1A CN114014883A (en) 2021-11-30 2021-11-30 Organic boron compound and application thereof in organic electroluminescent device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111444668.1A CN114014883A (en) 2021-11-30 2021-11-30 Organic boron compound and application thereof in organic electroluminescent device

Publications (1)

Publication Number Publication Date
CN114014883A true CN114014883A (en) 2022-02-08

Family

ID=80067229

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111444668.1A Pending CN114014883A (en) 2021-11-30 2021-11-30 Organic boron compound and application thereof in organic electroluminescent device

Country Status (1)

Country Link
CN (1) CN114014883A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109535131A (en) * 2018-12-25 2019-03-29 西安瑞联新材料股份有限公司 It is a kind of using cyanopyridine as the compound of receptor and its application
CN110452689A (en) * 2019-08-22 2019-11-15 武汉尚赛光电科技有限公司 A kind of electroluminescent organic material and organic electroluminescence device based on Triazolopyridine
CN110590770A (en) * 2019-08-22 2019-12-20 武汉尚赛光电科技有限公司 Triazolopyridine-based organic electroluminescent material and organic electroluminescent device
CN112778343A (en) * 2020-12-31 2021-05-11 武汉尚赛光电科技有限公司 Boron-based organic electroluminescent material and preparation method and application thereof
WO2021187939A1 (en) * 2020-03-19 2021-09-23 에스에프씨 주식회사 Novel boron compound and organic light-emitting element comprising same

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109535131A (en) * 2018-12-25 2019-03-29 西安瑞联新材料股份有限公司 It is a kind of using cyanopyridine as the compound of receptor and its application
CN110452689A (en) * 2019-08-22 2019-11-15 武汉尚赛光电科技有限公司 A kind of electroluminescent organic material and organic electroluminescence device based on Triazolopyridine
CN110590770A (en) * 2019-08-22 2019-12-20 武汉尚赛光电科技有限公司 Triazolopyridine-based organic electroluminescent material and organic electroluminescent device
WO2021187939A1 (en) * 2020-03-19 2021-09-23 에스에프씨 주식회사 Novel boron compound and organic light-emitting element comprising same
CN112778343A (en) * 2020-12-31 2021-05-11 武汉尚赛光电科技有限公司 Boron-based organic electroluminescent material and preparation method and application thereof

Similar Documents

Publication Publication Date Title
CN106986835B (en) Compound for organic electric element, organic electric element using same, and electronic device using same
KR20170037135A (en) Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof
KR20130007934A (en) Organic electroluminescence device using the triphenylene derivative
KR101912951B1 (en) Organic light-emitting compound and organic electroluminescent device using the same
KR20110129766A (en) Compound containing five membered heterocyclic compound, and organic electronic element using the same, terminal thereof
KR20150098062A (en) Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof
KR20160146023A (en) Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof
KR20150043669A (en) Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof
KR20100137243A (en) Anthracene derivative and organic electroluminescence device using the same
KR20170112913A (en) Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof
CN112679534B (en) Heterocyclic organic electroluminescent material, preparation method, application and device thereof
KR20180105882A (en) Compound for organic electric element, organic electric element comprising the same and electronic device thereof
JP7406260B2 (en) Compounds, light-emitting materials and light-emitting devices
KR20190037772A (en) Compound for organic electric element, organic electric element comprising the same and electronic device thereof
CN114292287A (en) Polycyclic compound, preparation method thereof and organic electroluminescent device
KR20180133097A (en) Compound for organic electric element, organic electric element comprising the same and electronic device thereof
KR20120020818A (en) Novel compounds for organic electronic material and organic electroluminescent device using the same
US11515488B2 (en) Thermally activated delayed fluorescence material having red, green, or blue color, synthesis method thereof, and application thereof
KR20180019880A (en) Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof
KR20130074803A (en) Novel compounds having arcridine structure and organic electroluminescence device using the same
CN112961175B (en) Polycyclic aromatic organic compound, synthesis process thereof, light-emitting material and organic electroluminescent device
KR20130051321A (en) Novel tetiary aryl amine and organic electroluminescent device using the same
KR20160065298A (en) Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof
KR101815653B1 (en) Azaboradibenzochrysene derivatives organic electroluminescent compound, ink composition and organic electroluminescent device
CN114133408B (en) Boron-based compound and application thereof in organic electroluminescent device

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination